{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F194-treatments-targeting-neurotransmitter-imbalances-june-2021-aXjh8G_P","width":444,"version":"1.0","type":"rich","title":"194 - Treatments targeting Neurotransmitter Imbalances: June 2021","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/cbc2ec80-c959-4f47-960f-d7e5da625a66/wordcloud-194-for-simplecast.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/556d8a25-aa95-44fd-9915-5f304ef54e26\" height=\"200\" width=\"100%\" title=\"194 - Treatments targeting Neurotransmitter Imbalances: June 2021\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode, Anusha will guide you through 20 papers that tackle acetylcholine and glutamate imbalances in Alzheimer's Disease. These papers were published in June of 2021 and address topics like inhibiting cholinesterases and NMDA receptors. We hope this information transmits to your neurons! \n \nSections in this episode: \nNovel Anti-Cholinesterase Drugs (2.39) \nExisting Anti-Cholinesterase Drugs (16.28) \nTargeting Glutamate (26.17) "}